Richard Hammock, MD
Family Medicine · Ozark, ALNPI 1497920276
Payments from drug & device makers
Across 17 payments — averaging $19.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Smith+Nephew$62
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$60
- Johnson & Johnson$42
- Kowa Pharmaceuticals America, Inc.$41
- Novo Nordisk$23
- Paratek Pharmaceuticals, Inc.$18
- plus $80 from 5 others
What the payments were for
- Food & beverage$327100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Smith+Nephew | 2 | $62 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $60 |
| Johnson & Johnson | 3 | $42 |
| Kowa Pharmaceuticals America, Inc. | 2 | $41 |
| Novo Nordisk | 1 | $23 |
| Paratek Pharmaceuticals, Inc. | 1 | $18 |
| Ossur Americas, Inc. | 1 | $18 |
| Kerecis Limited | 1 | $18 |
| Organogenesis Inc. | 1 | $17 |
| AbbVie | 1 | $16 |
| Lilly USA, LLC | 1 | $11 |
How this compares
$327 in reported general payments places this provider in the 35th percentile of 1,680 family medicine providers in Alabama.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 12 | $7,634 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 142 | $3,141 |
| Sucralfate | 13 | $1,378 |
| Hydralazine Hcl | 19 | $563 |
| Gabapentin | 49 | $558 |
| Cefdinir | 50 | $506 |
| Doxycycline Monohydrate | 35 | $347 |
| Tramadol Hcl | 37 | $273 |
| Ondansetron Hcl | 32 | $264 |
| Oxycodone Hcl | 22 | $219 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 17 | $202 |
| Potassium Chloride | 21 | $199 |
| Zolpidem Tartrate | 25 | $160 |
| Losartan Potassium | 13 | $131 |
| Alprazolam | 25 | $127 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Ozark
- Michael VaughnBirmingham$9.9M
- William NixonGuntersville$7.1M
- Randall QuinnCullman$5.4M
- Matthew CaldwellAthens$4.1M
- Michael CarterHuntsville$3.4M
- Howard RubensteinSaraland$3.3M
- Randle MiddletonHuntsville$3.3M
- Aaron KarrSheffield$3.1M
- Nidal MorrarFoley$3M
- Timothy HowardHuntsville$3M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.